Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Universe Pharmaceuticals (UPC) Other Gross PP&E Adjustments (2020 - 2025)

Universe Pharmaceuticals' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at $10.5 billion for Q3 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 2.49% to $10.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $10.5 billion, a 2.49% increase, with the full-year FY2025 number at $10.5 billion, up 2.49% from a year prior.
  • Other Gross PP&E Adjustments hit $10.5 billion in Q3 2025 for Universe Pharmaceuticals, up from $10.2 billion in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for UPC hit a ceiling of $10.5 billion in Q3 2025 and a floor of $9.8 million in Q3 2023.
  • Historically, Other Gross PP&E Adjustments has averaged $4.2 billion across 5 years, with a median of $10.5 million in 2021.
  • Biggest five-year swings in Other Gross PP&E Adjustments: fell 4.79% in 2022 and later surged 104847.16% in 2024.
  • Tracing UPC's Other Gross PP&E Adjustments over 5 years: stood at $10.5 million in 2021, then fell by 4.79% to $10.0 million in 2022, then decreased by 2.11% to $9.8 million in 2023, then surged by 104847.16% to $10.2 billion in 2024, then grew by 2.49% to $10.5 billion in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for UPC at $10.5 billion in Q3 2025, $10.2 billion in Q3 2024, and $9.8 million in Q3 2023.